MarketScreener Editorial Features Sarepta Therapeutics, Inc.
Equities
SRPT
US8036071004
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.64 USD | -2.18% |
|
-14.23% | -22.68% |
| 15/05 | Sarepta's Elevidys Faces 'Little' Pressure After Regenxbio Data, Wedbush Says | MT |
| 14/05 | Regenxbio shares sink as safety concerns overshadow muscle disorder therapy trial win | RE |
MarketScreener Editorial Features
Search
 | Analysts recommendations: Sarepta Therapeutics, Broadcom, Enphase Energy, Lam Research… | June 18, 2025 at 02:20 pm IST |
No results for this search
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition